Medicare’s restrictive coverage policies are denying patients with early Alzheimer’s disease access to novel treatments. And private payers are following suit.
Sue Peschin, MHS
Advertisement
Articles by Sue Peschin, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
‘Physician associate’ title gains momentum across state legislatures
2
How remote patient monitoring improves care while reducing costs
3
Who’s in control of medicine? Physicians on job autonomy and patient care
4
2025 state of claims: Does payer-provider collaboration need to improve?
5
